The NCAA and American College of Sports Medicine hosted a roundtable in March 2012 which brought together leading experts on sickle cell trait in athletics. The discussion focused on the growing literature surrounding the impact of sickle cell trait while exercising in an attempt to provide guidance for the recreational athlete and general public. The meeting included representatives from ACSM, American Society of Hematology, Centers for Disease Control and Prevention, National Collegiate Athletic Association, National Athletic Trainers’ Association, and the Korey Stringer Institute.
The consensus of the meeting follows. The group continues to work on the development of a fact sheet with ASCM; a scientific expert journal publication article; and the establishment of a research agenda for further study on the impact of sickle cell trait in the active individual.
Sickle cell trait is not a disease. It is a descriptive term for a hereditary condition in which an individual has one normal gene for hemoglobin (A) and one abnormal gene for hemoglobin (S), giving the genetic hemoglobin type (AS). Sickle cell trait is common in areas where malaria is endemic and provides a survival advantage against that disease. Having sickle cell trait (AS) is different from sickle cell disease (SS), in which two abnormal genes are present. Individuals with sickle cell trait commonly have ancestors from Africa, South or Central America, the Caribbean, Mediterranean countries, India, or Saudi Arabia. Even though sickle cell trait occurs in eight to ten percent of U.S. African-American population, it is present in athletes at all levels of competition and ethncities, including professional and Olympic.
Sickle Cell Trait is not a barrier to exercise or participation in sport. Persons with sickle cell trait alone do not have anemia and sickle cell trait cannot turn into sickle cell disease. There are more than four million people in the United States with sickle cell trait and very few experience any related complications. In general, sickle cell trait is a benign condition. No sports medicine body currently suggests exclusion from sport or exercise for the athlete with sickle cell trait.
Exercise and sport are safe and, in fact, may be somewhat protective in individuals with sickle cell trait. Regular exercise can lower blood viscosity, inflammation and oxidative stress in those with sickle cell trait and provides many positive health benefits in individuals both with and without sickle cell trait. It appears that problems can occur primarily with intense physical exertion when a coach or other individual is trying to push athletes to extreme physiologic limits or when an individual exercises intensely in the setting of illness (even relatively mild illness) or perhaps stimulant use. There is evidence in the laboratory and in the field that hydration can counteract or improve hematologic parameters in exercising individuals with sickle cell trait; therefore, paying careful attention to and ensuring adequate hydration may reduce clinical risk.
Sickle cell trait has been linked to an increased risk of exercise-associated sudden death in individuals undergoing intense physical exertion, and possibly rhabdomyolysis. Exercise-associated sudden death in individuals who have sickle cell trait most commonly occurs in those undergoing intense physical exertion such as military recruits in basic training and football athletes during conditioning workouts; although, it can occur in other sports and activities as well. The definitive contributing mechanisms for the increased risk of death are unknown; however, it is reported that at baseline individuals with sickle cell trait have increased blood viscosity, slightly reduced red blood cell deformability, increased red blood cell fragility and increased levels of inflammatory markers. The clinical implications of these distinguishing features are unknown.
Exertional rhabdomyolysis and exercise-associated death in those with sickle cell trait are hypothesized to occur because of micro-vascular occlusion in the capillary beds of the muscles leading to muscle cell breakdown and consequent release of intracellular contents potentially causing renal failure and/or cardiac arrhythmia. Clinically, when rhabdomyolysis occurs, it seems to present more quickly in athletes with sickle cell trait than those without. While the proposed underlying mechanisms seem to fit clinical observations, much more research is needed to determine the definitive cause of pathology and how or if sickle cell trait contributes. Although not well-documented in population-based studies, case reports provide evidence that individuals with sickle cell trait may also be at greater risk for non-fatal collapse.
Sickle cell trait has also been linked to an increased risk of splenic infarction, as well as an inability to concentrate urine. Splenic infarction typically occurs at high altitudes (usually greater than 5,000 feet), and symptoms may include sudden acute pain in the lower ribs, weakness and nausea. Strenuous physical exertion after a recent arrival at altitude may contribute to its development. Hyposthenuria (the inability to concentrate urine) occurs in most individuals with sickle cell trait and may contribute to dehydration.
Knowledge of one’s sickle cell trait status is an important piece of personal health information with possible health and genetic implications. All infants born in the U.S. and some other countries are tested at birth; but this information is not always communicated to the parents or, later in life, to the individual. Accordingly, the following points should be considered by healthcare providers for all athletes:
Serious medical problems associated with sickle cell trait are rare, even during intense athletic training, practice and competition; however, athletes with sickle cell trait have experienced significant physical distress, collapsed and even died.
Individuals with sickle cell trait should not be excluded from physical activity and sports participation unless warranted by medical personnel;
Workout design should consider an individual athlete’s medical condition, skills and abilities and conditioning level.
Prompt access to medical care and planned emergency response are critical components to ensure adequate response to an athlete who collapses or is in distress.
Everyone should know their sickle cell trait status. If unknown, individualized voluntary testing for sickle cell trait should be considered. If testing is performed, it must always be accompanied by education and counseling on the health implications of a positive or negative test, as well as genetic counseling. The athlete should be encouraged to share this information with medical professionals and coaching staff, as they would with any other piece of medical information.
All exercising individuals, including those with known sickle cell trait, should be counseled to:
Individuals with SCT should recognize variable signs and symptoms of physical distress. These may include: muscle “cramping” pain with weakness, while notably the muscles are usually not tense or hard, especially in the back or lower extremity; hyperventilation or difficulty to catch one’s breath; other muscle pain; abnormal general weakness; or undue fatigue.
Coaches should conduct appropriate sport-specific conditioning based on sound scientific principles and be ready to promptly intervene when athletes show signs of distress. Individuals should be allowed to self-limit their intensity and discontinue exercise when experiencing unusual fatigue and/or physical distress. NATA Inter-Association Task Force on Sudden Death
Ongoing, collaborative research in the area of exercise and sickle cell trait should be vigorously pursued with sport and sports medicine governing bodies and other appropriate medical associations and experts.
Last Updated: Jan 18, 2013